$ONMD

Yu Jeffrey purchased $100K of ONMD

Yu Jeffrey (Chief Medical Officer) purchased 158,730 shares of OneMedNet Corp (ONMD) at $0.63 on 2026-06-23.

Original reporting
SEC EDGAR · Yu Jeffrey
Published Jun 24, 2026, 1:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 24, 2026, 1:03 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$ONMD
Bullish
medium confidence
Mentioned
$ONMD
Relevance
4/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ONMDBullishLow
01

Why it matters

The newest fact is the disclosed open-market purchase size, price, and post-transaction holdings; it can influence sentiment but does not change fundamentals on its own.

02

Market read

Traders may treat this as a small positive signal, but without additional company-specific catalysts the tradable edge is limited.

03

What to watch

Check whether there is a broader sequence of insider buys/sells and whether the company has concurrent catalysts (financing, trial updates, contracts) not mentioned here.

Relevance 4/10Novelty 6/10Timing: filed 2026-06-24 (after-hours/next session) for a 2026-06-23 purchase

Background

The article is a primary-source SEC Form 4 insider transaction for OneMedNet (ONMD).

Company-level read

Ticker impact

$ONMDBullishMedium confidence
Context

OneMedNet CMO/10% owner Yu Jeffrey filed a Form 4 open-market purchase of 158,730 shares at $0.6300 on 2026-06-23.

Expected impact

Likely limited near-term impact; any effect is more sentiment/positioning than re-rating.

Evidence & confidence

The filing discloses a single open-market buy with no accompanying operational or guidance change; Form 4s often have muted price follow-through unless part of a larger pattern or paired with other news.

Market effects

Minimal; this is company-specific insider activity with no disclosed sector-wide development.

None indicated.

None indicated.

Counterpoint

The purchase may be routine (e.g., compensation-related liquidity needs) and lacks a 10b5-1 plan disclosure, so it may not reflect a strong forward view.

Key entities

  • OneMedNet Corp

    Subject of the Form 4 insider transaction; CMO/10% owner Yu Jeffrey bought shares.

  • Yu Jeffrey

    Chief Medical Officer and 10% owner; reported an open-market purchase.

Related articles